- Home
- CRIS vs ADGM Comparison
CRIS vs ADGM Comparison
Compare CRIS & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- ADGM
- Stock Information
- Founded
- CRIS 2000
- ADGM 2011
- Country
- CRIS United States
- ADGM United States
- Employees
- CRIS N/A
- ADGM N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- ADGM
- Sector
- CRIS Health Care
- ADGM
- Exchange
- CRIS Nasdaq
- ADGM NYSE
- Market Cap
- CRIS 31.2M
- ADGM 37.1M
- IPO Year
- CRIS 2000
- ADGM N/A
- Fundamental
- Price
- CRIS $3.99
- ADGM $3.00
- Analyst Decision
- CRIS Strong Buy
- ADGM
- Analyst Count
- CRIS 3
- ADGM 0
- Target Price
- CRIS $23.00
- ADGM N/A
- AVG Volume (30 Days)
- CRIS 72.6K
- ADGM 166.1K
- Earning Date
- CRIS 11-14-2024
- ADGM 11-14-2024
- Dividend Yield
- CRIS N/A
- ADGM N/A
- EPS Growth
- CRIS N/A
- ADGM N/A
- EPS
- CRIS N/A
- ADGM N/A
- Revenue
- CRIS $10,259,000.00
- ADGM $543,000.00
- Revenue This Year
- CRIS N/A
- ADGM N/A
- Revenue Next Year
- CRIS N/A
- ADGM N/A
- P/E Ratio
- CRIS N/A
- ADGM N/A
- Revenue Growth
- CRIS 0.44
- ADGM 187.30
- 52 Week Low
- CRIS $3.51
- ADGM $2.33
- 52 Week High
- CRIS $17.49
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- CRIS 31.48
- ADGM N/A
- Support Level
- CRIS $3.70
- ADGM N/A
- Resistance Level
- CRIS $4.55
- ADGM N/A
- Average True Range (ATR)
- CRIS 0.45
- ADGM 0.00
- MACD
- CRIS -0.04
- ADGM 0.00
- Stochastic Oscillator
- CRIS 32.21
- ADGM 0.00
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.